Canada’s collaboration-based research strategy

“At this early stage, one can see collaborations that never occurred before, and the introduction of collectively enriched research platforms that simply did not exist. Canada will be in a unique position to contribute in a significant way to tackling the growing global challenge of dementia.” –Dr. Yves Joanette & Joanne Goldberg, CIHR Institute of Aging

Learn More

Who we are

The Canadian Consortium on Neurodegeneration in Aging (CCNA) provides the infrastructure and support that facilitates collaboration amongst Canada’s top dementia researchers. By accelerating the discovery, innovation, and the adoption of new knowledge, the CCNA positions Canada as a global leader in increasing understanding of neurodegenerative diseases, working towards prevention, and improving the quality of life of those living with dementia.

Learn More


Call for CCNA Abstracts: CCNA Science Days 2018

Members of the CCNA research community are invited to submit abstracts for the CCNA Science Day poster sessions. This is an opportunity to showcase your work and foster collaborations with other CCNA investigators, trainees, and partner organizations. Abstracts must be submitted electronically no later than: 5:00 pm EST on Friday, July 13, 2018. Submit an…

New Knowledge on Leading Cause of Dementia for those Diagnosed Before 65

“Genetics is now widely applied to diagnosis, monitoring and the search for a potential treatment of neurodegenerative diseases. The ability to detect carriers of causal mutations could help evaluate the efficacy of therapies in clinical trials of individuals at either the pre-symptomatic or early disease stages. The detection of genetic modifiers of neurodegenerative diseases, including…

Our Partners

Go back to top